Edition:
India

Eiger BioPharmaceuticals Inc (EIGR.OQ)

EIGR.OQ on NASDAQ Stock Exchange Global Market

8.90USD
1:30am IST
Change (% chg)

$-1.05 (-10.55%)
Prev Close
$9.95
Open
$10.00
Day's High
$10.00
Day's Low
$8.90
Volume
22,885
Avg. Vol
35,157
52-wk High
$16.15
52-wk Low
$6.15

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -1.01 December 25 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 5 5 5 5
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.17 1.17 1.17 1.17

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 4 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 4 0.00 0.00 0.00 0.00
Year Ending Dec-18 6 0.00 0.00 0.00 0.00
Year Ending Dec-19 6 2.08 12.47 0.00 12.47
Earnings (per share)
Quarter Ending Jun-18 6 -1.01 -0.61 -1.19 -1.64
Quarter Ending Sep-18 6 -1.00 -0.53 -1.26 -1.60
Year Ending Dec-18 6 -4.24 -2.32 -5.31 -5.06
Year Ending Dec-19 6 -3.80 -2.42 -5.10 -4.94

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 0.00 0.00 0.00 0.00
Quarter Ending Sep-17 0.00 0.00 0.00 0.00
Quarter Ending Jun-17 0.00 0.00 0.00 0.00
Quarter Ending Dec-16 0.00 0.00 0.00 0.00
Quarter Ending Sep-16 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 0.00 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 0.00 0.00 0.00 0.00 0.00
Year Ending Dec-18 0.00 0.00 0.00 0.00 0.00
Year Ending Dec-19 2.08 2.08 2.08 2.08 12.47

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings